1,041 research outputs found
Barriers to gender-equitable HIV testing: going beyond routine screening for pregnant women in Nova Scotia, Canada
<p>Abstract</p> <p>Background</p> <p>Women and men face different gender-based health inequities in relation to HIV, including HIV testing as well as different challenges in accessing HIV care, treatment and support programs and services when testing HIV-positive. In this article, we discuss the findings of a mixed methods study exploring the various individual and structural barriers and facilitators to HIV counselling and testing experienced among a sample of adult women and men living in Nova Scotia, Canada.</p> <p>Methods</p> <p>Drawing from testing demographics, qualitative interview data and a review of existing testing policies and research, this paper focuses on understanding the gendered health inequities and their implications for HIV testing rates and behaviours in Nova Scotia.</p> <p>Results</p> <p>The findings of this research serve as the basis to further our understanding of gender as a key determinant of health in relation to HIV testing. Recognizing gender as a key determinant of health in terms of both vulnerability to HIV and access to testing, this paper explores how gender intersects with health equity issues such as access to HIV testing, stigma and discrimination, and sexual behaviours and relationships.</p> <p>Conclusions</p> <p>Drawing on the current gender and HIV literatures, in conjunction with our data, we argue that an enhanced, gender-based, context-dependent approach to HIV counselling and testing service provision is required in order to address the health equity needs of diverse groups of women and men living in various settings. Further, we argue that enhanced HIV testing efforts must be inclusive of both men and women, addressing uniquely gendered barriers to accessing HIV counselling and testing services and in the process moving beyond routine HIV testing for pregnant women.</p
Removing Orbital Debris with Lasers
Orbital debris in low Earth orbit (LEO) are now sufficiently dense that the
use of LEO space is threatened by runaway collisional cascading. A problem
predicted more than thirty years ago, the threat from debris larger than about
1 cm demands serious attention. A promising proposed solution uses a high power
pulsed laser system on the Earth to make plasma jets on the objects, slowing
them slightly, and causing them to re-enter and burn up in the atmosphere. In
this paper, we reassess this approach in light of recent advances in low-cost,
light-weight modular design for large mirrors, calculations of laser-induced
orbit changes and in design of repetitive, multi-kilojoule lasers, that build
on inertial fusion research. These advances now suggest that laser orbital
debris removal (LODR) is the most cost-effective way to mitigate the debris
problem. No other solutions have been proposed that address the whole problem
of large and small debris. A LODR system will have multiple uses beyond debris
removal. International cooperation will be essential for building and operating
such a system.Comment: 37 pages, 15 figures, in preparation for submission to Advances in
Space Researc
High-temperature performance of ferritic steels in fireside corrosion regimes: temperature and deposits
The paper reports high temperature resistance of ferritic steels in fireside corrosion regime in terms of temperature and deposits aggressiveness. Four candidate power plant steels: 15Mo3, T22, T23 and T91 were exposed under simulated air-fired combustion environment for 1000 h. The tests were conducted at 600, 650 and 700 °C according to deposit-recoat test method. Post-exposed samples were examined via dimensional metrology (the main route to quantify metal loss), and mass change data were recorded to perform the study of kinetic behavior at elevated temperatures. Microstructural investigations using ESEM-EDX were performed in order to investigate corrosion degradation and thickness of the scales. The ranking of the steels from most to the least damage was 15Mo3 > T22 > T23 > T91 in all three temperatures. The highest rate of corrosion in all temperatures occurred under the screening deposit
Quality of life and wellbeing among HIV outpatients in East Africa: a multicentre observational study
Adaptive response and enlargement of dynamic range
Many membrane channels and receptors exhibit adaptive, or desensitized,
response to a strong sustained input stimulus, often supported by protein
activity-dependent inactivation. Adaptive response is thought to be related to
various cellular functions such as homeostasis and enlargement of dynamic range
by background compensation. Here we study the quantitative relation between
adaptive response and background compensation within a modeling framework. We
show that any particular type of adaptive response is neither sufficient nor
necessary for adaptive enlargement of dynamic range. In particular a precise
adaptive response, where system activity is maintained at a constant level at
steady state, does not ensure a large dynamic range neither in input signal nor
in system output. A general mechanism for input dynamic range enlargement can
come about from the activity-dependent modulation of protein responsiveness by
multiple biochemical modification, regardless of the type of adaptive response
it induces. Therefore hierarchical biochemical processes such as methylation
and phosphorylation are natural candidates to induce this property in signaling
systems.Comment: Corrected typos, minor text revision
The Ghrelin Signalling System Is Involved in the Consumption of Sweets
The gastric-derived orexigenic peptide ghrelin affects brain circuits involved in energy balance as well as in reward. Indeed, ghrelin activates an important reward circuit involved in natural- as well as drug-induced reward, the cholinergic-dopaminergic reward link. It has been hypothesized that there is a common reward mechanism for alcohol and sweet substances in both animals and humans. Alcohol dependent individuals have higher craving for sweets than do healthy controls and the hedonic response to sweet taste may, at least in part, depend on genetic factors. Rat selectively bred for high sucrose intake have higher alcohol consumption than non-sucrose preferring rats and vice versa. In the present study a group of alcohol-consuming individuals selected from a population cohort was investigated for genetic variants of the ghrelin signalling system in relation to both their alcohol and sucrose consumption. Moreover, the effects of GHS-R1A antagonism on voluntary sucrose- intake and operant self-administration, as well as saccharin intake were investigated in preclinical studies using rodents. The effects of peripheral grelin administration on sucrose intake were also examined. Here we found associations with the ghrelin gene haplotypes and increased sucrose consumption, and a trend for the same association was seen in the high alcohol consumers. The preclinical data show that a GHS-R1A antagonist reduces the intake and self-administration of sucrose in rats as well as saccharin intake in mice. Further, ghrelin increases the intake of sucrose in rats. Collectively, our data provide a clear indication that the GHS-R1A antagonists reduces and ghrelin increases the intake of rewarding substances and hence, the central ghrelin signalling system provides a novel target for the development of drug strategies to treat addictive behaviours
Assessment of a rapid liquid-based cytology method for measuring sputum cell counts
Differential sputum cell counting is not widely available despite proven clinical utility in the management of asthma. We compared eosinophil counts obtained using liquid-based cytology (LBC), a routine histopathological processing method, and the current standard method. Eosinophil counts obtained using LBC were a strong predictor of sputum eosinophilia (≥3%) determined by the standard method suggesting LBC could be used in the management of asthma
Multivariate Modelling of Pedestrian Fatality Risk Through on the Spot Accident Investigation
Pedestrians are the most vulnerable users of public roads and represent one of the largest groups of road casualties; their death rate around the world due to vehicle-pedestrian collisions is high and tending to rise. In Spain, as in other countries of the European Union, steps have been taken to reduce the number and consequences of such accidents, with encouraging results in recent years. A key to countering this concern is the accident research activity that has obtained remarkable achievements in different fields, especially when multidisciplinary approaches are taken. This paper describes the development of a multivariate model that is able to detect the most influential parameters on the consequences of vehicle-pedestrian collision and to quantify their impact on pedestrian fatality risk. First, an accident database containing detailed information and parameters of vehicle-pedestrian collisions in Madrid has been developed. The accidents were investigated on the spot by INSIA accident investigation teams and analyzed using advanced reconstruction techniques. The model was then developed with two components: (1) a classification tree that characterizes and selects the explanatory variables, identifying their interactions, and (2) a binary logistic regression to quantify the influence of each variable and interaction resulting from the classification tree. The whole model represents an important tool for identifying, quantifying and predicting the potential impact of measures aimed at reducing injuries in vehicle-pedestrian collisions
Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies
Background: Exposure in utero to certain medications can disrupt processes of fetal development, including brain development, leading to a continuum of neurodevelopmental difficulties. Recognizing the deficiency of neurodevelopmental investigations within pregnancy pharmacovigilance, an international Neurodevelopmental Expert Working Group was convened to achieve consensus regarding the core neurodevelopmental outcomes, optimization of methodological approaches and barriers to conducting pregnancy pharmacovigilance studies with neurodevelopmental outcomes. Methods: A modified Delphi study was undertaken based on stakeholder and expert input. Stakeholders (patient, pharmaceutical, academic and regulatory) were invited to define topics, pertaining to neurodevelopmental investigations in medication-exposed pregnancies. Experts were identified for their experience regarding neurodevelopmental outcomes following medicinal, substances of misuse or environmental exposures in utero. Two questionnaire rounds and a virtual discussion meeting were used to explore expert opinion on the topics identified by the stakeholders. Results: Twenty-five experts, from 13 countries and professionally diverse backgrounds took part in the development of 11 recommendations. The recommendations focus on the importance of neurodevelopment as a core feature of pregnancy pharmacovigilance, the timing of study initiation and a core set of distinct but interrelated neurodevelopmental skills or diagnoses which require investigation. Studies should start in infancy with an extended period of investigation into adolescence, with more frequent sampling during rapid periods of development. Additionally, recommendations are made regarding optimal approach to neurodevelopmental outcome measurement, comparator groups, exposure factors, a core set of confounding and mediating variables, attrition, reporting of results and the required improvements in funding for potential later emerging effects. Different study designs will be required depending on the specific neurodevelopmental outcome type under investigation and whether the medicine in question is newly approved or already in widespread use. Conclusion: An improved focus on neurodevelopmental outcomes is required within pregnancy pharmacovigilance. These expert recommendations should be met across a complementary set of studies which converge to form a comprehensive set of evidence regarding neurodevelopmental outcomes in pregnancy pharmacovigilance
- …